Cargando…

Clustering of human prion protein and α-synuclein oligomers requires the prion protein N-terminus

The interaction of prion protein (PrP) and α-synuclein (αSyn) oligomers causes synaptic impairment that might trigger Parkinson’s disease and other synucleinopathies. Here, we report that αSyn oligomers (αSynO) cluster with human PrP (huPrP) into micron-sized condensates. Multivalency of αSyn within...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rösener, Nadine S., Gremer, Lothar, Wördehoff, Michael M., Kupreichyk, Tatsiana, Etzkorn, Manuel, Neudecker, Philipp, Hoyer, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347944/ https://www.ncbi.nlm.nih.gov/pubmed/32647130 http://dx.doi.org/10.1038/s42003-020-1085-z

Ejemplares similares

Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy
por: König, Anna S., et al.
Publicado: (2021)

In Vitro and In Vivo Neurotoxicity of Prion Protein Oligomers
por: Simoneau, Steve, et al.
Publicado: (2007)

Unique Properties of the Rabbit Prion Protein Oligomer
por: Yu, Ziyao, et al.
Publicado: (2016)

The N-terminus of the prion protein is a toxic effector regulated by the C-terminus
por: Wu, Bei, et al.
Publicado: (2017)

The Prion 2018 round tables (II): Aβ, tau, α-synuclein… are they prions, prion-like proteins, or what?
por: Eraña, Hasier
Publicado: (2019)

Atomic Resolution Insights into pH Shift Induced Deprotonation Events in LS-Shaped Aβ(1–42) Amyloid Fibrils
por: Becker, Nina, et al.
Publicado: (2023)

Metabolism of minor isoforms of prion proteins: Cytosolic prion protein and transmembrane prion protein
por: Song, Zhiqi, et al.
Publicado: (2013)

Opposed Effects of Dityrosine Formation in Soluble and Aggregated α-Synuclein on Fibril Growth
por: Wördehoff, Michael M., et al.
Publicado: (2017)

Structural Determinants of the Prion Protein N-Terminus and Its Adducts with Copper Ions
por: Sánchez-López, Carolina, et al.
Publicado: (2018)

Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons
por: Urrea, Laura, et al.
Publicado: (2017)

Prion Protein-mediated Toxicity of Amyloid-β Oligomers Requires Lipid Rafts and the Transmembrane LRP1
por: Rushworth, Jo V., et al.
Publicado: (2013)

Treatment of Prion Disease with Heterologous Prion Proteins
por: Skinner, Pamela J., et al.
Publicado: (2015)

Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers
por: Laurén, Juha, et al.
Publicado: (2009)

From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein
por: Heras-Garvin, Antonio, et al.
Publicado: (2020)

α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation
por: Falke, Marcel, et al.
Publicado: (2019)

Met/Val129 polymorphism of the full-length human prion protein dictates distinct pathways of amyloid formation
por: Pauly, Thomas, et al.
Publicado: (2022)

α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication
por: Aulić, Suzana, et al.
Publicado: (2017)

Emergence and evolution of yeast prion and prion-like proteins
por: An, Lu, et al.
Publicado: (2016)

Editorial: Prion and prion-like proteins in neurodegenerative diseases
por: Toni, Mattia, et al.
Publicado: (2022)

The prion-like transmission of tau oligomers via exosomes
por: Jackson, Noel A., et al.
Publicado: (2022)

Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
por: Shafiq, Mohsin, et al.
Publicado: (2021)

The role of heat shock proteins in preventing amyloid toxicity
por: Törner, Ricarda, et al.
Publicado: (2022)

Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein
por: Makarava, Natallia, et al.
Publicado: (2018)

Conservation of Prion-Like Composition and Sequence in Prion-Formers and Prion-Like Proteins of Saccharomyces cerevisiae
por: Su, Ting-Yi, et al.
Publicado: (2019)

Protein-only prions
por: Wells, William A.
Publicado: (2004)

Prion Protein in Milk
por: Franscini, Nicola, et al.
Publicado: (2006)

Prion Protein Misfolding
por: Kupfer, L, et al.
Publicado: (2009)

Prion protein and aging
por: Gasperini, Lisa, et al.
Publicado: (2014)

The protean prion protein
por: Requena, Jesús R.
Publicado: (2020)

Prion protein self-peptides modulate prion interactions and conversion
por: Rigter, Alan, et al.
Publicado: (2009)

Recombinant Human Prion Protein Inhibits Prion Propagation in vitro
por: Yuan, Jue, et al.
Publicado: (2013)

The Elusive Role of the Prion Protein and the Mechanism of Toxicity in Prion Disease
por: Chiesa, Roberto
Publicado: (2015)

Yeast Prions: Proteins Templating Conformation and an Anti-prion System
por: Wickner, Reed B., et al.
Publicado: (2015)

Potential approaches for heterologous prion protein treatment of prion diseases
por: Seelig, Davis M., et al.
Publicado: (2015)

Endoproteolysis of cellular prion protein by plasmin hinders propagation of prions
por: Mays, Charles E., et al.
Publicado: (2022)

Recombinant Mammalian Prions: The “Correctly” Misfolded Prion Protein Conformers
por: Ma, Jiyan, et al.
Publicado: (2022)

Prion protein—Semisynthetic prion protein (PrP) variants with posttranslational modifications
por: Hackl, Stefanie, et al.
Publicado: (2019)

An N-terminal Fragment of the Prion Protein Binds to Amyloid-β Oligomers and Inhibits Their Neurotoxicity in Vivo
por: Fluharty, Brian R., et al.
Publicado: (2013)

Accumulation of cellular prion protein within β‐amyloid oligomer plaques in aged human brains
por: Takahashi, Reisuke H., et al.
Publicado: (2021)

Novel strain properties distinguishing sporadic prion diseases sharing prion protein genotype and prion type
por: Cracco, Laura, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3f85igvcsf0j0kti7cbtmvfg05